PE34096A1 - Derivado triciclico del pirazol - Google Patents
Derivado triciclico del pirazolInfo
- Publication number
- PE34096A1 PE34096A1 PE1995275579A PE27557995A PE34096A1 PE 34096 A1 PE34096 A1 PE 34096A1 PE 1995275579 A PE1995275579 A PE 1995275579A PE 27557995 A PE27557995 A PE 27557995A PE 34096 A1 PE34096 A1 PE 34096A1
- Authority
- PE
- Peru
- Prior art keywords
- hydrogen
- lower alkyl
- compound
- preference
- pyrazole
- Prior art date
Links
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical class C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000002131 composite material Substances 0.000 abstract 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 2
- -1 AMINO GROUP Chemical group 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical class [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I DONDE: R1 A R4 SIGNIFICAN CADA UNO HIDROGENO, HIDROXILO, HALOGENO, ALQUILO INFERIOR, ALCOXILO INFERIOR O FENILO, R2 ES DE PREFERENCIA METILO O METOXILO; R1, R3, R4 Y R6 SON DE PREFERENCIA HIDROGENO; R5 SIGNIFICA HIDROGENO o ALQUILO INFERIOR, DE PREFERENCIA METILO; R6 SIGNIFICA HIDROGENO, ALQUILO INFERIOR o ALCOXILO INFERIOR; X SIGNIFICA -(CR7R8)n o -CH=CH-, DE PREFERENCIA -CH2-; R7 y R8 SIGNIFICAN HIDROGENO o ALQUILO INFERIOR; n SIGNIFICA 1 o 2; ADEMAS SE REFIERE AL PROCEDIMIENTO DE OBTENCION QUE COMPRENDE LA CONVERSION DE UN COMPUESTO DE FORMULA GENERAL IIa, DONDE DE R1 A R6 y X YA ESTAN DEFINIDOS y R91 SIGNIFICA UN GRUPO CONVERTIBLE EN UN GRUPO AMINO, EN EL CORRESPONDIENTE COMPUESTO AMINO DE FORMULA I. ESTE COMPUESTO ES UTILIZADO EN EL TRATAMIENTO O PREVENCION DE TRANSTORNOS DEL S.N.C
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH249094 | 1994-08-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE34096A1 true PE34096A1 (es) | 1996-10-04 |
Family
ID=4234975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1995275579A PE34096A1 (es) | 1994-08-12 | 1995-08-08 | Derivado triciclico del pirazol |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US5561150A (es) |
| EP (1) | EP0700905B1 (es) |
| JP (1) | JP2755560B2 (es) |
| KR (1) | KR100385384B1 (es) |
| CN (1) | CN1056607C (es) |
| AT (1) | ATE207905T1 (es) |
| AU (1) | AU691310B2 (es) |
| BR (1) | BR9503630A (es) |
| CA (1) | CA2153937C (es) |
| CO (1) | CO4410331A1 (es) |
| CZ (1) | CZ289027B6 (es) |
| DE (1) | DE59509777D1 (es) |
| DK (1) | DK0700905T3 (es) |
| ES (1) | ES2164730T3 (es) |
| FI (1) | FI113264B (es) |
| HK (1) | HK1012342A1 (es) |
| HU (1) | HUT72066A (es) |
| IL (1) | IL114849A (es) |
| MA (1) | MA23643A1 (es) |
| MY (1) | MY133619A (es) |
| NO (1) | NO305026B1 (es) |
| NZ (1) | NZ272731A (es) |
| PE (1) | PE34096A1 (es) |
| PH (1) | PH31424A (es) |
| PL (1) | PL182480B1 (es) |
| PT (1) | PT700905E (es) |
| RU (1) | RU2152388C1 (es) |
| TR (1) | TR199500977A2 (es) |
| TW (1) | TW403738B (es) |
| UY (1) | UY24016A1 (es) |
| ZA (1) | ZA956553B (es) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU727654B2 (en) * | 1997-06-13 | 2000-12-21 | Yamanouchi Pharmaceutical Co., Ltd. | Tricyclic pyrazole derivative |
| US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
| US6960579B1 (en) | 1998-05-19 | 2005-11-01 | Alcon Manufacturing, Ltd. | Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders |
| GB9819019D0 (en) * | 1998-09-01 | 1998-10-28 | Cerebrus Ltd | Chemical compounds II |
| GB9820767D0 (en) * | 1998-09-23 | 1998-11-18 | Cerebrus Ltd | Chemical compounds VIII |
| GB9918965D0 (en) * | 1999-08-11 | 1999-10-13 | Cerebrus Ltd | Chemical compounds xxi |
| GB9918962D0 (en) | 1999-08-11 | 1999-10-13 | Cerebrus Ltd | Chemical compounds xxii |
| US20040048844A1 (en) * | 1999-10-20 | 2004-03-11 | Bristol-Myers Squibb Pharma Company | Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| US6291504B1 (en) * | 1999-10-20 | 2001-09-18 | Dupont Pharmaceuticals Company | Acylsemicarbazides and their uses |
| EP1132389A1 (en) | 2000-03-06 | 2001-09-12 | Vernalis Research Limited | New aza-indolyl derivatives for the treatment of obesity |
| DE60117247D1 (de) * | 2000-03-31 | 2006-04-20 | Purdue Research Foundation West Lafayette | Phosphoramidat-prodrugs |
| WO2004098807A1 (en) * | 2000-11-21 | 2004-11-18 | Barsplice Products, Inc. | Method of making steel couplers for joining concrete reinforcing bars |
| CA2432122A1 (en) | 2000-12-20 | 2002-08-01 | Bristol-Myers Squibb Pharma Company | Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
| WO2002098350A2 (en) * | 2001-06-01 | 2002-12-12 | Alcon, Inc. | Pyranoindazoles and their use for the treatment of glaucoma |
| EP1392658A4 (en) * | 2001-06-01 | 2004-10-13 | Alcon Inc | NOVEL FUSED INDAZOLES AND INDOLES AND THEIR USE IN THE TREATMENT OF GLAUCOMES |
| US6884816B2 (en) * | 2001-08-31 | 2005-04-26 | Alcon, Inc. | Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma |
| US20070197664A1 (en) * | 2001-11-29 | 2007-08-23 | Steiner Mitchell S | Prevention and treatment of androgen-deprivation induced osteoporosis |
| US20050080143A1 (en) * | 2001-11-29 | 2005-04-14 | Steiner Mitchell S. | Treatment of androgen-deprivation induced osteoporosis |
| US20060269611A1 (en) * | 2001-11-29 | 2006-11-30 | Steiner Mitchell S | Prevention and treatment of androgen-deprivation induced osteoporosis |
| US20040214898A1 (en) * | 2001-11-29 | 2004-10-28 | Steiner Mitchell S. | Methods for treating hot flashes |
| US20080249183A1 (en) * | 2001-11-29 | 2008-10-09 | Steiner Mitchell S | Treatment of androgen-deprivation induced osteoporosis |
| TW593302B (en) * | 2001-12-20 | 2004-06-21 | Alcon Inc | Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| WO2003057161A2 (en) * | 2001-12-28 | 2003-07-17 | Bayer Pharmaceuticals Corporation | BENZOTHIENO [3,2-c]PYRAZOLYL AND BENZOFURANO [3,2-c] PYRAZOLYL COMPOUNDS, THEIR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR AND INTERMEDIATE COMPOUNDS THEREOF |
| CA2471880A1 (en) * | 2001-12-28 | 2003-07-17 | Bayer Pharmaceuticals Corporation | 1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| JP2005517681A (ja) * | 2001-12-28 | 2005-06-16 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | ５−ｈｔ２ｃ受容体と関連する疾患における使用のための４−スルフィド／スルホキシド／スルホニル−１ｈ−ピラゾリル誘導体化合物 |
| PL375564A1 (en) * | 2002-08-30 | 2005-11-28 | Alcon, Inc. | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma |
| EP1581209A4 (en) * | 2002-12-13 | 2009-03-11 | Alcon Inc | NEW BENZOPYRAN ANALOGUE AND ITS USE FOR THE TREATMENT OF GLAUKOM |
| WO2005053688A1 (en) * | 2003-11-26 | 2005-06-16 | Alcon, Inc. | Substituted furo[2,3-g] indazoles for the treatment of glaucoma |
| US7129257B1 (en) | 2003-12-15 | 2006-10-31 | Alcon, Inc. | Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma |
| US7338972B1 (en) | 2003-12-15 | 2008-03-04 | Alcon, Inc. | Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma |
| US6989445B2 (en) * | 2003-12-15 | 2006-01-24 | Alcon, Inc. | Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma |
| WO2006062839A1 (en) * | 2004-12-08 | 2006-06-15 | Alcon, Inc. | Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma |
| TW200744567A (en) * | 2005-09-23 | 2007-12-16 | Alcon Inc | Phenylethylamine analogs and their use for treating glaucoma |
| WO2007149728A2 (en) * | 2006-06-20 | 2007-12-27 | Alcon Research, Ltd. | Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US392430A (en) * | 1888-11-06 | Tubular lantern | ||
| GB1228792A (es) * | 1967-07-20 | 1971-04-21 | ||
| BE789948A (fr) * | 1971-10-13 | 1973-04-11 | Sandoz Sa | Nouveaux derives du pyrazole, leur preparation et leur application comme medicaments |
-
1995
- 1995-07-10 TW TW084107125A patent/TW403738B/zh not_active IP Right Cessation
- 1995-07-14 CA CA002153937A patent/CA2153937C/en not_active Expired - Fee Related
- 1995-08-02 US US08/510,153 patent/US5561150A/en not_active Expired - Lifetime
- 1995-08-04 HU HU9502310A patent/HUT72066A/hu unknown
- 1995-08-04 AT AT95112270T patent/ATE207905T1/de not_active IP Right Cessation
- 1995-08-04 EP EP95112270A patent/EP0700905B1/de not_active Expired - Lifetime
- 1995-08-04 DK DK95112270T patent/DK0700905T3/da active
- 1995-08-04 DE DE59509777T patent/DE59509777D1/de not_active Expired - Fee Related
- 1995-08-04 ES ES95112270T patent/ES2164730T3/es not_active Expired - Lifetime
- 1995-08-04 ZA ZA956553A patent/ZA956553B/xx unknown
- 1995-08-04 PT PT95112270T patent/PT700905E/pt unknown
- 1995-08-07 NZ NZ272731A patent/NZ272731A/en unknown
- 1995-08-07 AU AU28382/95A patent/AU691310B2/en not_active Ceased
- 1995-08-07 CZ CZ19952013A patent/CZ289027B6/cs not_active IP Right Cessation
- 1995-08-07 IL IL11484995A patent/IL114849A/xx not_active IP Right Cessation
- 1995-08-08 MA MA23984A patent/MA23643A1/fr unknown
- 1995-08-08 RU RU95113149/04A patent/RU2152388C1/ru not_active IP Right Cessation
- 1995-08-08 PE PE1995275579A patent/PE34096A1/es not_active Application Discontinuation
- 1995-08-08 TR TR95/00977A patent/TR199500977A2/xx unknown
- 1995-08-09 JP JP7203040A patent/JP2755560B2/ja not_active Expired - Fee Related
- 1995-08-10 CN CN95115544A patent/CN1056607C/zh not_active Expired - Fee Related
- 1995-08-10 CO CO95035750A patent/CO4410331A1/es unknown
- 1995-08-10 KR KR1019950024636A patent/KR100385384B1/ko not_active Expired - Fee Related
- 1995-08-10 MY MYPI95002335A patent/MY133619A/en unknown
- 1995-08-10 PH PH51087A patent/PH31424A/en unknown
- 1995-08-10 PL PL95309974A patent/PL182480B1/pl unknown
- 1995-08-11 UY UY24016A patent/UY24016A1/es unknown
- 1995-08-11 NO NO953162A patent/NO305026B1/no unknown
- 1995-08-11 FI FI953827A patent/FI113264B/fi not_active IP Right Cessation
- 1995-08-11 BR BR9503630A patent/BR9503630A/pt not_active IP Right Cessation
-
1998
- 1998-12-15 HK HK98113447A patent/HK1012342A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE34096A1 (es) | Derivado triciclico del pirazol | |
| HUP0000079A2 (hu) | Indán- és dihidroindolszármazékok | |
| PE91798A1 (es) | Pirrolicarboxanilidas condensadas: utiles como ligandos receptores | |
| AR240929A2 (es) | "n-piridinsulfonil-n'-piridinil-y-triazinil-ureas procedimiento parasu preparacion, intermediarios para uso exclusivo en dicho procedimiento, y composiciones que contienen dichas ureas" | |
| EA199700156A1 (ru) | Производные индола как антагонисты рецептора 5-нт | |
| NZ331860A (en) | Piperazine and piperidine compounds with affinity for both dopamine D2 and seratonin 5-HT1A receptors | |
| NO20072115L (no) | Farmasoytiske forbindelser | |
| DE69415614D1 (de) | N-acylierte trizyklische Azaheteroringe verwendbar als Vasopressin-Antagonisten | |
| PE20010641A1 (es) | Derivados de piperazina como antagonistas del receptor de serotonina 5-ht1b | |
| ES2166954T3 (es) | Derivados de 1-fenilpirazol y su uso como agentes parasiticidas. | |
| CO5590915A2 (es) | Derivados de piperidina como antagonistas nk1 ( receptor del neuropeptido neuroquinina-1) con actividad antagonista superior en tratamientos de trastornos fisiologicos y disminucion de efectos colaterales | |
| ATE139783T1 (de) | Azasteroide zur behandlung prostatischer hypertrophie, ihre herstellung und verwendung | |
| CO5550421A2 (es) | Derivados de indol utiles para el tratamiento de enfermeda- des | |
| DE3789967D1 (de) | Anwendung von monoaminakridinen bei mangelerscheinungen des cholinergen nervensystems. | |
| PE20021067A1 (es) | Empleo de antagonistas del receptor nk3 | |
| ES2052675T3 (es) | 3-(4-piperazinil-sustituido en 1)butil)-4-tiazolidinonas, un procedimiento para su preparacion y su uso como medicamentos. | |
| CO5680438A2 (es) | Uso de derivados de ciclotiocarbamato en tratamiento de condiciones relacionadas con hormonas | |
| EA199700111A1 (ru) | Трициклические бензазепиновые антагонисты вазопрессина | |
| ATE247639T1 (de) | Arylsubstituierte cyclische amine als selektive dopamin-d3-liganden | |
| DE69903333D1 (de) | Crf rezeptor-antagonisten und darauf bezogene methoden | |
| CO4650117A1 (es) | Derivados de bencilsulfuro y proceso para su produccion . | |
| PE20021043A1 (es) | DERIVADOS DE PIRAZINO[1,2-a]INDOL COMO AGONISTAS DEL RECEPTOR 5HT2 | |
| AR009266A1 (es) | Un derivado de aciloamino alquenilen-amida, un proceso para su preparacion y una composicion farmaceutica que lo comprende | |
| DE69323712D1 (de) | Indol derivate zur behandlung von migräne | |
| ES2192584T3 (es) | Derivado pirimidinilpirazol. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |